CTKB

Cytek Biosciences, Inc.

6.50

Top Statistics
Market Cap 837 M Forward PE 30.59 Revenue Growth 7.30 %
Current Ratio 6.21 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -5.05 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -37.87 Enterprise / Revenue 2.85 Price To Sales Trailing12 Months 4.16
Profitability
Profit Margins -5.05 % Operating Margins -8.25 %
Balance Sheet
Total Cash 277 M Total Cash Per Share 2.16 Total Debt 14 M
Total Debt To Equity 3.77 Current Ratio 6.21 Book Value Per Share 2.97
All Measures
Short Ratio 501.00 % Message Board Id finmb_422081633 Shares Short Prior Month 4 M
Return On Equity -0.0254 City Fremont Uuid a1084d55-a899-3c3b-840b-c763cdf83566
Previous Close 6.41 First Trade Date Epoch Utc 1 B Book Value 2.97
Beta 1.32 Total Debt 14 M Volume 562765
Price To Book 2.19 Fifty Two Week Low 4.66 Total Cash Per Share 2.16
Total Revenue 201 M Shares Short Previous Month Date 1 B Target Median Price 8.50
Audit Risk 10 Max Age 86400 Recommendation Mean 2.00
Sand P52 Week Change 0.3133 Operating Margins -8.25 % Target Mean Price 8.40
Net Income To Common -10160000 Short Percent Of Float 0.0411 Implied Shares Outstanding 128 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 616760
Average Volume10days 616760 Total Cash 277 M Next Fiscal Year End 1 B
Revenue Per Share 1.53 Held Percent Insiders 0.0885 Ebitda Margins -7.53 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 8 Regular Market Previous Close 6.41 Target Low Price 7.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.60 Open 6.49
Free Cashflow 40 M State CA Dividend Yield 0.00 %
Return On Assets -0.0274 Time Zone Short Name EST Board Risk 8
Trailing Eps -0.0800 Day Low 6.40 Address1 47215 Lakeview Boulevard
Shares Outstanding 128 M Compensation Risk 8 Price Hint 2
Target High Price 9.00 Website https://cytekbio.com 52 Week Change -0.0634
Average Volume 695559 Forward Eps 0.0600 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 526.20 % Is_sp_500 False
Regular Market Day High 6.56 Profit Margins -5.05 % Debt To Equity 3.77
Fifty Two Week High 9.87 Day High 6.56 Shares Short 4 M
Regular Market Open 6.49 Industry Key medical-devices Earnings Growth 0.00 %
Enterprise To Revenue 2.85 Revenue Growth 7.30 % Shares Percent Shares Out 0.0319
Operating Cashflow 32 M Currency USD Time Zone Full Name America/New_York
Market Cap 837 M Is_nasdaq_100 False Zip 94538
Quote Type EQUITY Industry Medical Devices Long Name Cytek Biosciences, Inc.
Overall Risk 9 Regular Market Day Low 6.40 Held Percent Institutions 0.5902
Current Price 6.50 Enterprise To Ebitda -37.87 Financial Currency USD
Current Ratio 6.21 Gross Margins 54.92 % Industry Disp Medical Devices
Number Of Analyst Opinions 5 Country United States Float Shares 110 M
Two Hundred Day Average 6.07 Governance Epoch Date 1 B Enterprise Value 574 M
Price To Sales Trailing12 Months 4.16 Forward PE 30.59 Regular Market Volume 562765
Ebitda -15157000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems.

The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils.

In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools.

The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations.

It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries.

The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015.

Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.